Works matching DE "BROMOCRIPTINE"

Results: 517

The effectiveness and safety of aripiprazole, bromocriptine, and cabergoline in the treatment of hyperprolactinemia: a systematic review and network meta-analysis.

Published in:

Expert Opinion on Drug Safety, 2025, v. 24, n. 7, p. 773, doi. 10.1080/14740338.2024.2416918

By:

Ma, Kun;
Ma, Linna;
Huang, Tianjiao;
Wang, Yue;
Zhong, Guanlan;
Gao, Cong;
Zhou, Zhiyu;
Luo, Jie

Publication type:

Article

Kolloid Kist Operasyonuna Bağlı Apatinin Bromokriptin ile Tedavisi: Bir Olgu Sunumu.

Published in:

Klinik Psikofarmakoloji Bulteni, 2007, v. 17, n. 3, p. 138

By:

Ulaş, Halis;
Tunca, Zeliha;
Yıldız, Ayşegül

Publication type:

Article

Therapeutic effects of Wharton jelly-derived mesenchymal stem cells on rat abortion models.

Published in:

Journal of Obstetrics & Gynaecology Research, 2016, v. 42, n. 8, p. 972, doi. 10.1111/jog.12984

By:

Chen, Xiaojing;
Yang, Xiaoqing;
Wu, Rongrong;
Chen, Weiwei;
Xie, Huihui;
Qian, Xia;
Zhang, Yuquan

Publication type:

Article

Management of medically refractory prolactinoma.

Published in:

Journal of Neuro-Oncology, 2014, v. 117, n. 3, p. 421, doi. 10.1007/s11060-013-1270-8

By:

Molitch, Mark

Publication type:

Article

Low levels of PRB3 mRNA are associated with dopamine-agonist resistance and tumor recurrence in prolactinomas.

Published in:

Journal of Neuro-Oncology, 2014, v. 116, n. 1, p. 83, doi. 10.1007/s11060-013-1276-2

By:

Wang, Fei;
Gao, Hua;
Li, Chuzhong;
Bai, Jiwei;
Lu, Runchun;
Cao, Lei;
Wu, Yongtu;
Hong, Lichuan;
Wu, Yonggang;
Lan, Xiaolei;
Zhang, Yazhuo

Publication type:

Article

Clinical management and outcome of 36 invasive prolactinomas treated with dopamine agonist.

Published in:

Journal of Neuro-Oncology, 2011, v. 104, n. 1, p. 195, doi. 10.1007/s11060-010-0459-3

By:

Yang, Moon;
Hong, Jae;
Lee, Seung;
Lee, Eun;
Kim, Sun

Publication type:

Article

Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.

Published in:

Molecular Medicine, 2023, v. 29, n. 1, p. 1, doi. 10.1186/s10020-023-00664-z

By:

Wilk, Elizabeth J.;
Howton, Timothy C.;
Fisher, Jennifer L.;
Oza, Vishal H.;
Brownlee, Ryan T.;
McPherson, Kasi C.;
Cleary, Hannah L.;
Yoder, Bradley K.;
George, James F.;
Mrug, Michal;
Lasseigne, Brittany N.

Publication type:

Article

Age-related decrease in the opioid control of LH secretion during reproductive years in normal women.

Published in:

1997

By:

Coiro, V.;
Voipi, R.;
Gramellini, D.;
Cigarini, C.;
Magotti, M.G.;
Caffarri, G.;
Chiodera, P.;
Volpi, R

Publication type:

journal article

Tolerability, safety and efficacy of two formulations of Parlodel--a slow release oral form (SRO) versus registered Parlodel capsules.

Published in:

1994

By:

Biberoğlu, Kutay;
Atasü, Turgay;
Shabgahi, Biuck;
Kandemir, Ömer;
Biberoğlu, K;
Atasü, T;
Shabgahi, B;
Kandemir, O

Publication type:

journal article

Cabergoline versus bromocriptine in suppression of lactation after cesarean delivery.

Published in:

1991

By:

Giorda, Giorgio;
de Vincentiis, Sangrila;
Motta, Tiziano;
Casazza, Silvano;
Fadin, Mario;
D'Alberton, Alberto;
Giorda, G;
de Vincentiis, S;
Motta, T;
Casazza, S;
Fadin, M;
D'Alberton, A

Publication type:

journal article

Puerperal lactation, gonadotropin release and estradiol release: effects of metergoline and bromocriptine.

Published in:

1987

By:

Pontiroli, A.E.;
Di Micco, R.;
Sartani, A.;
de Pasqua, A.;
Zanardi, E.

Publication type:

journal article

Pulsatile luteinizing hormone secretion and clomiphene and bromocriptine response in amenorrheic women with normoprolactinemia and gestagen withdrawal bleeding.

Published in:

1987

By:

Morishita, Hajime;
Kondo, Hajime;
Nishiuchi, Ken;
Kuroiwa, Shunichiro;
Tomioka, Michio;
Morishita, H;
Kondo, H;
Nishiuchi, K;
Kuroiwa, S;
Tomioka, M

Publication type:

journal article

Hyperprolactinemic primary amenorrhea: case report with successful prolactin-lowering treatment and review of the literature.

Published in:

1980

By:

Farrari, C;
Telloli, P;
Rampini, P;
Caldara, R

Publication type:

journal article

Effect of Dopamine Agonist Treatment on Glycemic Control in Patients with Lipodystrophy.

Published in:

Endocrinology Research & Practice, 2024, v. 28, n. 3, p. 181, doi. 10.5152/erp.2024.24414

By:

Şimşir, Ilgın Yıldırım;
Özgür, Su;
Soyaltın, Utku Erdem;
Çetinkalp, Şevki

Publication type:

Article

Pregnancy and Pituitary Diseases.

Published in:

Endocrinology Research & Practice, 2024, v. 28, n. 2, p. 121, doi. 10.5152/erp.2024.23291

By:

Urhan, Emre;
Karaca, Züleyha

Publication type:

Article

ASSOCIATION OF THE ANTIDIABETIC EFFECTS OF BROMOCRIPTINE WITH A SHIFT IN THE DAILY RHYTHM OF MONOAMINE METABOLISM WITHIN THE SUPRACHIASMATIC NUCLEI OF THE SYRIAN HAMSTER.

Published in:

Chronobiology International: The Journal of Biological & Medical Rhythm Research, 2000, v. 17, n. 2, p. 155, doi. 10.1081/CBI-100101040

By:

Luo, Shuqin;
Luo, Jing;
Cincotta, Anthony H.

Publication type:

Article

The Effect of Bromocriptine Mesylate and Heat Stress on Innate and Adaptive Immune Function in Beef Cattle.

Published in:

2022

By:

Zeltwanger, Joshua M.;
Bailey, Eric;
Spiers, Don;
Petzel, Emily;
Nelson, Benjamin;
Brake, Derek

Publication type:

Abstract

Inhibition of prolactin promotes secondary skin follicle activation in cashmere goats.

Published in:

Journal of Animal Science, 2021, v. 99, n. 4, p. 1, doi. 10.1093/jas/skab079

By:

Zhang, Lechao;
Duan, Chunhui;
Guo, Yunxia;
Zhang, Yingjie;
Liu, Yueqin

Publication type:

Article

Raynaud's phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report.

Published in:

Revista Latinoamericana de Hipertension, 2021, v. 16, n. 2, p. 176, doi. 10.5281/zenodo.5514223

By:

González-Fernández, Laura;
Añez-Ramos, Roberto José;
Rivas-Montenegro, Alejandra Maricel;
Muñoz Moreno, Diego;
Percovich-Hualpa, Juan Carlos

Publication type:

Article

Response to Caroff and Mann.

Published in:

Journal of Intensive Care Medicine, 1998, v. 13, n. 3, p. 151, doi. 10.1177/088506669801300308

By:

Fricchione, Gregory L.;
Fricchione

Publication type:

Article

Bromocriptine quick‐release as adjunct therapy in youth and adults with type 1 diabetes: A randomized, placebo‐controlled crossover study.

Published in:

Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2148, doi. 10.1111/dom.14800

By:

Tell, Shoshana S.;
Schafer, Michal;
Vigers, Timothy;
Baumgartner, Amy D.;
Lyon, Ellen;
Gross, Susan;
Polsky, Sarit;
Snell‐Bergeon, Janet K.;
Schauer, Irene E.;
Nadeau, Kristen J.

Publication type:

Article

Why does quick-release bromocriptine decrease cardiac events?

Published in:

Diabetes, Obesity & Metabolism, 2011, v. 13, n. 10, p. 880, doi. 10.1111/j.1463-1326.2011.01424.x

By:

Bell, D. S. H.

Publication type:

Article

Bromocriptine: old drug, new formulation and new indication.

Published in:

Diabetes, Obesity & Metabolism, 2010, v. 12, n. 12, p. 1048, doi. 10.1111/j.1463-1326.2010.01304.x

By:

Holt, R. I. G.;
Barnett, A. H.;
Bailey, C. J.

Publication type:

Article

Simultaneous Determination of Ascorbic Acid, Dopamine and Uric Acid Based on Gold Nanoparticles-PTCA-Cys Composites Modified Electrodes.

Published in:

Journal of the Chinese Chemical Society, 2015, v. 62, n. 8, p. 739, doi. 10.1002/jccs.201500118

By:

Li, Feng;
Chai, Yaqin;
Yuan, Ruo;
Li, Xin;
Yang, Yuqiao

Publication type:

Article

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy.

Published in:

Clinical Endocrinology, 1998, v. 48, n. 1, p. 103, doi. 10.1046/j.1365-2265.1998.00360.x

By:

Popovic;
Simic;
Ilic;
Micic;
Damjanovic;
Djurovic;
Obradovic;
Dieguez;
Casanueva;
Popovic, Vera

Publication type:

Article

Central Hyperthermia Treated with Bromocriptine.

Published in:

2017

By:

Natteru, P.;
George, P.;
Bell, R.;
Nattanmai, P.;
Newey, C. R.

Publication type:

Case Study

Reverse Takotsubo syndrome, a case report of a rare cause for postpartum heart failure.

Published in:

2018

By:

Kilian, Leo;
Haaf, Philip;
Pfister, Otmar;
Vischer, Annina S.;
Lapaire, Olav;
Burkard, Thilo

Publication type:

Case Study

Darkening of white hair in Parkinson's disease.

Published in:

Clinical & Experimental Dermatology, 1989, v. 14, n. 5, p. 317, doi. 10.1111/j.1365-2230.1989.tb01992.x

By:

Reynolds, N. J.;
Crossley, J.;
Ferguson, I.;
Peachey, R. D.G.

Publication type:

Article

Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 2, p. 358, doi. 10.4143/crt.2016.017

By:

Jinxiang Huang;
Fenglin Zhang;
Lei Jiang;
Guohan Hu;
Wei Sun;
Chenran Zhang;
Xuehua Ding

Publication type:

Article

Early weaning alters the thermogenic capacity of brown adipose tissue in adult male and female rats.

Published in:

European Journal of Nutrition, 2020, v. 59, n. 5, p. 2207, doi. 10.1007/s00394-019-02071-9

By:

Peixoto, T. C.;
Pietrobon, C. B.;
Bertasso, I. M.;
Caramez, F. A. H.;
Calvino, C.;
Santos, T. R.;
Oliveira, E.;
Moura, E. G.;
Lisboa, P. C.

Publication type:

Article

Bromocriptine mitigated paliperidone metabolic and neuro-hormonal side effects and improved negative domain in a case of early onset schizophrenia.

Published in:

Nordic Journal of Psychiatry, 2016, v. 70, n. 4, p. 318, doi. 10.3109/08039488.2015.1094127

By:

Naguy, Ahmed;
Al-Tajali, Ali

Publication type:

Article

Clinical experience with bromocriptine for central hyperthermia after brain insult.

Published in:

Brain Injury, 2024, v. 38, n. 8, p. 652, doi. 10.1080/02699052.2024.2337231

By:

Amin, Suneri J.;
Aghajan, Yasmin;
Webb, Andrew J.

Publication type:

Article

EFFECT OF DOPAMINE AGONIST (BROMOCRIPTINE MESYLATE) VS HUMAN ALBUMIN FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME(OHSS).

Published in:

Medical Channel, 2010, v. 16, n. 3, p. 432

By:

PERVEEN, SAJIDA;
KHANAM, MAJIDA;
BAILIE, PETER;
HASSAN, SHEHNAZ

Publication type:

Article

Effects of engineered conserved dopamine neurotrophic factor-expressing bone marrow stromal cells on dopaminergic neurons following 6-OHDA administrations.

Published in:

Molecular Medicine Reports, 2015, v. 11, n. 2, p. 1207, doi. 10.3892/mmr.2014.2878

By:

JIAMING MEI;
CHAOSHI NIU

Publication type:

Article

Bromocriptine reduces cigarette smoking.

Published in:

Addiction, 2000, v. 95, n. 8, p. 173, doi. 10.1046/j.1360-0443.2000.95811734.x

By:

Jarvik, Murray E.;
Caskey, Nicholas H.;
Wirshing, William C.;
Madsen, Damian C.;
Iwamoto-Schaap, Paula N.;
Elins, Julie L.;
Eisenberger, Naomi I.;
Olmstead, Richard E.

Publication type:

Article

Long-acting injectable bromocriptine does not reduce relapse in alcoholics.

Published in:

Addiction, 1997, v. 92, n. 8, p. 969, doi. 10.1111/j.1360-0443.1997.tb02976.x

By:

Naranjo, C.A.;
Dongier, M.

Publication type:

Article

Induction of Oestrus and Fertility Response using Bromocriptine, Cabergoline and eCG Plus hCG Treatment Protocols in Female Dogs.

Published in:

Indian Journal of Animal Research, 2022, v. 56, n. 12, p. 1462, doi. 10.18805/IJAR.B-4208

By:

Bisen, Abhisek;
Shukla, S. N.;
Baghel, R. P. S.;
Mishra, Aditya

Publication type:

Article

Recognition and determination of bovine hemoglobin using a gold electrode modified with gold nanoparticles and molecularly imprinted self-polymerized dopamine.

Published in:

Microchimica Acta, 2015, v. 182, n. 15/16, p. 2477, doi. 10.1007/s00604-015-1594-5

By:

Li, Lu;
Fan, Limei;
Dai, Yunlong;
Kan, Xianwen

Publication type:

Article

The neuroleptic malignant syndrome—a systematic case series analysis focusing on therapy regimes and outcome.

Published in:

Acta Psychiatrica Scandinavica, 2020, v. 142, n. 3, p. 233, doi. 10.1111/acps.13215

By:

Kuhlwilm, L.;
Schönfeldt‐Lecuona, C.;
Gahr, M.;
Connemann, B. J.;
Keller, F.;
Sartorius, A.

Publication type:

Article

Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and D-Amphetamine Cross-Sensitization following Sex Abstinence.

Published in:

Journal of Neuroscience, 2016, v. 36, n. 38, p. 9949, doi. 10.1523/JNEUROSCI.0937-16.2016

By:

Beloate, Lauren N.;
Omrani, Azar;
Adan, Roger A.;
Webb, Ian C.;
Coolen, Lique M.

Publication type:

Article

Dosage-Dependent Effect of Dopamine D<sub>2</sub> Receptor Activation on Motor Cortex Plasticity in Humans.

Published in:

Journal of Neuroscience, 2014, v. 34, n. 32, p. 10701, doi. 10.1523/JNEUROSCI.0832-14.2014

By:

Fresnoza, Shane;
Stiksrud, Elisabeth;
Klinker, Florian;
Liebetanz, David;
Paulus, Walter;
Kuo, Min-Fang;
Nitsche, Michael A.

Publication type:

Article

Treatment of Hepatic Encephalopathy.

Published in:

American Journal of Gastroenterology (Springer Nature), 1997, v. 92, n. 9, p. 1429

By:

Córdoba, Juan;
Blei, Andres T.

Publication type:

Article

A randomized, double-blind, placebo-controlled trial to assess safety and tolerability during treatment of type 2 diabetes with usual diabetes therapy and either Cycloset or placebo.

Published in:

BMC Endocrine Disorders, 2007, v. 7, p. 3, doi. 10.1186/1472-6823-7-3

By:

Scranton, Richard E.;
Gaziano, J. Michael;
Rutty, Dean;
Ezrokhi, Michael;
Cincotta, Anthony

Publication type:

Article

Drugs affecting milk supply during lactation.

Published in:

Australian Prescriber, 2018, v. 41, n. 1, p. 7, doi. 10.18773/austprescr.2018.002

By:

McGuire, Treasure M.

Publication type:

Article

Ocena stanu psychicznego pacjentek w trakcie jednoczesnego stosowania leków psychotropowych, w tym leków przeciwpsychotycznych, oraz bromokryptyny.

Published in:

Psychiatria Polska, 2008, v. 42, n. 4, p. 595

By:

Barszcz, Zbigniew;
Mucha, Sławomir;
Rabe-Jabłońska, Jolanta

Publication type:

Article

Musical hallucinations induced by bromocriptine.

Published in:

Psychogeriatrics, 2004, v. 4, n. 3, p. 102, doi. 10.1111/j.1479-8301.2004.00056.x

By:

Kobayashi, Toshiyuki;
Miyata, Yoshifumi;
Okamoto, Shuhei;
Kato, Satoshi

Publication type:

Article

An observational study of pregnancy and post‐partum outcomes in women with prolactinoma treated with dopamine agonists.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2020, v. 60, n. 3, p. 405, doi. 10.1111/ajo.13070

By:

O'Sullivan, Susannah M.;
Farrant, Maritza T.;
Ogilvie, Cara M.;
Gunn, Alistair J.;
Milsom, Stella R.

Publication type:

Article

Pharmacological lactation suppression with D<sub>2</sub> receptor agonists and risk of postpartum psychosis: A systematic review.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2016, v. 56, n. 4, p. 336, doi. 10.1111/ajo.12479

By:

Snellen, Martien;
Power, Josephine;
Blankley, Gaynor;
Galbally, Megan

Publication type:

Article

Indication for bromocriptine in peripartum cardiomyopathy: reply.

Published in:

2009

By:

Habedank, Dirk;
Haverkamp, Wilhelm;
Dudenhausen, Joachim W.;
Dietz, Rainer

Publication type:

Letter

Indication for bromocriptine in peripartum cardiomyopathy.

Published in:

2009

By:

Mouquet, Frederic;
Lamblin, Nicolas;
de Groote, Pascal

Publication type:

Letter